Cellebrite DI (CLBT) Other Operating Expenses (2020 - 2025)

Cellebrite DI's Other Operating Expenses history runs 6 years deep, the most recent figure standing at $37.0 million for Q4 2025.

• In Q4 2025, Other Operating Expenses rose 4.08% year-over-year to $37.0 million; the TTM figure through Dec 2025 stood at $153.1 million (up 15.81% YoY), while the FY2025 annual figure was $151.0 million, up 14.25% from the prior year.
• Other Operating Expenses was $37.0 million for Q4 2025 at Cellebrite DI, down from $38.6 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $120.2 million in Q4 2022 to a low of -$81.3 million in Q4 2023.
• Historically, Other Operating Expenses has averaged $24.1 million across 5 years, with a median of $27.2 million in 2023.
• Biggest YoY gain for Other Operating Expenses was 498.98% in 2022; the steepest drop was 226.33% in 2022.
• A 5-year view of Other Operating Expenses shows it stood at $20.1 million in 2021, then surged by 498.98% to $120.2 million in 2022, then slumped by 167.69% to -$81.3 million in 2023, then soared by 143.67% to $35.5 million in 2024, then grew by 4.08% to $37.0 million in 2025.
• The last three Other Operating Expenses figures came in at $37.0 million (Q4 2025), $38.6 million (Q3 2025), and $38.7 million (Q2 2025), per Business Quant data.